References
- Knudsen A, Malmberg CA, Kjaer A, et al. Low prevalence of peripheral arterial disease in a cross-sectional study of Danish HIV-infected patients. Infect Dis (Lond). 2015;47:776–782.
- Rotger M, Glass TR, Junier T, et al. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Clin Infect Dis. 2013;57:112–121.
- Nordell AD, McKenna M, Borges AH, et al. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014;3:e000844.
- Borges AH, O’Connor JL, Phillips AN, et al. Factors associated with D-dimer levels in HIV-infected individuals. PLoS One. 2014;9:e90978.
- Reber G, de Moerloose P. D-dimer assays for the exclusion of venous thromboembolism. Semin Thromb Hemost. 2000;26:619–624.
- Olson JD, Cunningham MT, Higgins RA, et al. D-dimer: simple test, tough problems. Arch Pathol Lab Med. 2013;137:1030–1038.
- Longstaff C, Adcock D, Olson JD, et al. Harmonisation of D-dimer – a call for action. Thromb Res. 2016;137:219–220.
- Crowther MA, Bates SM, Keeney M, et al. Human-derived D-dimer for external quality assessment: results of four surveys in Ontario. Am J Clin Pathol. 2008;130:805–810.
- Dempfle CE, Zips S, Ergul H, et al. The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer. Thromb Haemost. 2001;86:1204–1209.
- Oude Elferink RF, Loot AE, van de Klashorst CG, et al. Clinical evaluation of eight different D-dimer tests for the exclusion of deep venous thrombosis in primary care patients. Scand J Clin Lab Invest. 2015;75:230–238.
- Dempfle CE, Wurst M, Smolinski M, et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost. 2004;91:812–818.